- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Outsourcing in China and India: A Comparison
Outsourcing in China and India: A Comparison
Contract Research Organizations (CROs) in China and India offer a low cost alternative for pharmaceutical companies that are looking to outsource RD activities.
Posted
Posted on 01 September 2009by Jim J Zhang, president and MD, JZMed; Jiawen Shen, University of Science and Technology Beijing
The
The global pharmaceutical industry is facing a number of challenges. Companies today need to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in RD or manufacturing. The key to a quick turnaround is to have drugs discovered quicker,
developed faster, manufactured cheaper and marketed more widely.
Outsourcing is one method that helps drug companies by providing them with the desired
efficiency, flexibility and agility. Among the emerging countries, China and India have risen rapidly in the global pharmaceutical outsourcing arena, as both countries possess the unique combination of low cost and quality service. The current global financial crisis
has also enhanced the importance of these two countries to many drug companies around
the world that are seeking cost reductions.
China and India each possess their own unique features and characteristics, not only in
the pharma-related industries but also in almost every aspect of the social structure. To many companies that are interested in conducting outsourcing or looking to invest in either of these countries, it is a challenge to decide on the one that best fits the companys investment goals.
Compare and Contrast
An in-depth study was conducted for the comparison of pharma outsourcing service industries between China and India. This article summarizes the results in a number of areas. It reveals the similarities and differences between these two countries, their advantages and disadvantages in pharma outsourcing, and their strengths and weaknesses in service capabilities.
The investigation of
您可能关注的文档
最近下载
- 北京市西城区2025-2026学年高一上学期期末考试 物理含答案 .pdf VIP
- 微生物发酵机制.pptx VIP
- 施工场地已具备施工条件的证明.doc VIP
- 2025年福州城市建设投资集团公司治理结构组织架构和部门职能.docx
- GM_T 0027-2014 清晰版 智能密码钥匙技术规范.docx VIP
- 2025年轮机英语问答题答案全 .pdf VIP
- 微生物代谢产物发酵.pptx VIP
- 新教材-普通高中教科书物理教师用书选择性必修1 电子版.pdf VIP
- 砖厂突发环境事件应急预案.pdf VIP
- 高中政治部编版必修四《哲学与文化》全册知识点填空练习(分单元课时编排)(附参考答案)(2023秋最新版).pdf VIP
文档评论(0)